17-N-Allylamino-17-Demethoxygeldanamycin With or Without Rituximab in Treating Patients With Relapsed B-Cell Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia

This study has been completed.

Study NCT00098488 Information provided by National Cancer Institute (NCI)

First Received: December 7, 2004 Last Updated: February 6, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	April 2008 (Final data collection date for primary outcome measure)